All Companies

Company Description Statussort icon Initial Date
<a href="/venture-capital/all-companies/perseptive-biosystems">PerSeptive BioSystems</a> Developer of high-technology purification, analysis and synthesis products Acquired 1991 View Profile
<a href="/venture-capital/all-companies/aveo-pharmaceuticals-inc">AVEO Pharmaceuticals, Inc.</a> Discovering, developing and commercializing cancer therapeutics. Public 2003 View Profile
<a href="/venture-capital/all-companies/bg-medicine-inc">BG Medicine, Inc.</a> Developing and delivering diagnostic solutions to aid in the clinical management of heart failure and related disorders. Public 2000 View Profile
<a href="/venture-capital/all-companies/agios-pharmaceuticals-inc">Agios Pharmaceuticals, Inc.</a> Discovering and developing novel drugs to treat cancer and inborn errors of metabolism. Public 2007 View Profile
<a href="/venture-capital/all-companies/zalicus">Zalicus</a> Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Public 2002 View Profile
<a href="/venture-capital/all-companies/concert-pharmaceuticals-inc">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. Public 2006 View Profile
<a href="/venture-capital/all-companies/acceleron-pharma-inc">Acceleron Pharma, Inc.</a> Discovering, developing and commercializing novel protein therapeutics for cancer and rare diseases. Public 2004 View Profile
<a href="/venture-capital/all-companies/bind-therapeutics-inc">BIND Therapeutics, Inc.</a> Developing Accurins, its novel targeted therapeutics. Public 2007 View Profile
<a href="/venture-capital/all-companies/eleven-biotherapeutics-inc">Eleven Biotherapeutics, Inc.</a> Discovering and developing protein therapeutics to treat diseases of the eye. Public 2008 View Profile
<a href="/venture-capital/all-companies/receptos-inc">Receptos, Inc.</a> Developing therapeutic candidates for the treatment of immune and metabolic diseases. Public 2009 View Profile
<a href="/venture-capital/all-companies/tetraphase-pharmaceuticals-inc">Tetraphase Pharmaceuticals, Inc.</a> Creating novel antibiotics for serious and life-threatening multidrug-resistant (MDR) bacterial infections. Public 2006 View Profile
<a href="/venture-capital/all-companies/adolor-corporation">Adolor Corporation</a> Discovery, development and commercialization of prescription pain management products Public 1996 View Profile
<a href="/venture-capital/all-companies/insmed-incorporated">INSMED, Incorporated</a> Pharmaceuticals for treatment of metabolic diseases and endocrine disorders Public 1996 View Profile
<a href="/venture-capital/all-companies/idexx-laboratories">IDEXX Laboratories</a> Products that enhance the ability of veterinarians to economically provide advanced medical care Public 1991 View Profile
<a href="/venture-capital/all-companies/cytyc">CYTYC</a> Design, development, manufacturing, and marketing of medical devices focused on women's health Public 1989 View Profile
<a href="/venture-capital/all-companies/antigenics">Antigenics</a> Technology and products to treat cancers, infectious diseases, and autoimmune disorders Public 1994 View Profile
<a href="/venture-capital/all-companies/celera">Celera</a> Sequenced human genome; now focused on therapeutics for cancer and other diseases Public 1998 View Profile
<a href="/venture-capital/all-companies/exact-sciences">EXACT Sciences</a> Proprietary technologies for the early detection, monitoring and staging of common cancers Public 1995 View Profile
<a href="/venture-capital/all-companies/renovis">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders Public 2000 View Profile
<a href="/venture-capital/all-companies/affinnova-inc">Affinnova, Inc.</a> Improving innovation and marketing success rates. Private 2000 View Profile